These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20444639)

  • 1. Recent advances in the development of oncolytic viruses as cancer therapeutics. Foreword.
    Bell J; Kirn D
    Cytokine Growth Factor Rev; 2010; 21(2-3):83-4. PubMed ID: 20444639
    [No Abstract]   [Full Text] [Related]  

  • 2. United virus: the oncolytic tag-team against cancer!
    Le Boeuf F; Bell JC
    Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy progress and prospects cancer: oncolytic viruses.
    Liu TC; Kirn D
    Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining oncolytic virotherapy and tumour vaccination.
    Bridle BW; Hanson S; Lichty BD
    Cytokine Growth Factor Rev; 2010; 21(2-3):143-8. PubMed ID: 20226716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic parvoviruses as cancer therapeutics.
    Rommelaere J; Geletneky K; Angelova AL; Daeffler L; Dinsart C; Kiprianova I; Schlehofer JR; Raykov Z
    Cytokine Growth Factor Rev; 2010; 21(2-3):185-95. PubMed ID: 20211577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic virotherapy of gynecologic malignancies.
    Hartkopf AD; Fehm T; Wallwiener D; Lauer U
    Gynecol Oncol; 2011 Feb; 120(2):302-10. PubMed ID: 21145097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of tumour cells for delivering oncolytic viruses.
    Raykov Z; Rommelaere J
    Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the battle between oncolytic viruses and tumours.
    Parato KA; Senger D; Forsyth PA; Bell JC
    Nat Rev Cancer; 2005 Dec; 5(12):965-76. PubMed ID: 16294217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic viruses and histone deacetylase inhibitors--a multi-pronged strategy to target tumor cells.
    Nguyen TL; Wilson MG; Hiscott J
    Cytokine Growth Factor Rev; 2010; 21(2-3):153-9. PubMed ID: 20395162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval.
    Breitbach CJ; Reid T; Burke J; Bell JC; Kirn DH
    Cytokine Growth Factor Rev; 2010; 21(2-3):85-9. PubMed ID: 20472490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally oncolytic viruses.
    Roberts MS; Lorence RM; Groene WS; Bamat MK
    Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic virotherapy for cancer treatment: challenges and solutions.
    Davis JJ; Fang B
    J Gene Med; 2005 Nov; 7(11):1380-9. PubMed ID: 16025557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic viruses move forward in clinical trials.
    Rowan K
    J Natl Cancer Inst; 2010 May; 102(9):590-5. PubMed ID: 20421567
    [No Abstract]   [Full Text] [Related]  

  • 16. ReVOLT: radiation-enhanced viral oncolytic therapy.
    Advani SJ; Mezhir JJ; Roizman B; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):637-46. PubMed ID: 17011442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.
    Liu TC; Kirn D
    Cancer Res; 2007 Jan; 67(2):429-32. PubMed ID: 17234747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A call to arms: using RNAi screening to improve oncolytic viral therapy.
    Mahoney DJ; Stojdl DF
    Cytokine Growth Factor Rev; 2010; 21(2-3):161-7. PubMed ID: 20207578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy.
    Yun CO
    Curr Opin Mol Ther; 2008 Aug; 10(4):356-61. PubMed ID: 18683100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses.
    De Silva N; Atkins H; Kirn DH; Bell JC; Breitbach CJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):135-41. PubMed ID: 20338801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.